Novozymes Other Non-Current Liabilities 2011-2024 | NVZMY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Novozymes other non-current liabilities for 2024 were $0.157B, a 328.82% increase from 2023.
Novozymes other non-current liabilities for 2023 were $0.037B, a 76.57% decline from 2022.
Novozymes other non-current liabilities for 2022 were $0.156B, a 30.53% decline from 2021.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Novozymes other non-current liabilities for 2024 were $0.157B, a 328.82% increase from 2023.
Novozymes other non-current liabilities for 2023 were $0.037B, a 76.57% decline from 2022.
Novozymes other non-current liabilities for 2022 were $0.156B, a 30.53% decline from 2021.

Related Stocks
Company Name	Market Cap
Linde (LIN)	$220B
Sherwin-Williams (SHW)	$88.6B
Ecolab (ECL)	$75.4B
Givaudan SA (GVDNY)	$40.1B
PPG Industries (PPG)	$27.1B
International Flavors & Fragrances (IFF)	$21B
Symrise AG (SYIEY)	$13.9B
Axalta Coating Systems (AXTA)	$8.1B
Element Solutions (ESI)	$6.7B
Arcadium Lithium (ALTM)	$6.3B
Celanese (CE)	$6B
Croda (COIHY)	$5.6B
Balchem (BCPC)	$5.3B
CSW Industrials (CSWI)	$5.3B
NewMarket (NEU)	$5.2B
Nissan Chemical (NNCHY)	$3.7B
H B Fuller (FUL)	$3.2B
Ashland (ASH)	$3.1B
Sensient Technologies (SXT)	$3B
Quaker Houghton (KWR)	$2.5B
Hawkins (HWKN)	$2.3B
Minerals Technologies (MTX)	$2.3B
Ingevity (NGVT)	$1.8B
Perimeter Solutions, SA (PRM)	$1.7B
DAQO New Energy (DQ)	$1.5B
Orbia Advance, S.A.B De C.V (MXCHY)	$1.5B
ELEMENTIS (ELMTY)	$1.1B
Huabao Holdings (HUIHY)	$943M
Westlake Chemical Partners LP (WLKP)	$852M
Orion S.A (OEC)	$846M